RapidPulse, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RapidPulse, Inc. - overview
Location
Miami, FL, US
Primary Industry
Medical Devices & Equipment
About
Based in Florida, US, RapidPulse, Inc. operates as a medical device company that develops minimally invasive vascular products for ischemic stroke. The company is a spinout of Syntheon LLC. , a medical device incubator designed to develop innovative products in the medical device industry.
RapidPulse is headed by its CEO Sean McBrayer, and is backed by Santé Ventures, Epidarex Capital, Hatteras Venture Partners, Broadview Ventures, and Syntheon LLC from a Series A funding round in June 2021. RapidPulse develops the Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse plans to advance its system through expanded clinical evaluation, build out its platform of proprietary catheters, and move towards regulatory approval in the United States.
Current Investors
Hatteras Venture Partners, Sante Ventures, Epidarex Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.rapidpulsemed.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.